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Introduction
H
epatitis C virus (HCV) is a single stranded 
enveloped positive sense RNA virus belonging 
to  the  Flaviviridae  family,  and  is  associated  with 
significant  morbidity  and  mortality  in  men  and  in 
women  (1).  The  infection  is  a  major  public  health 
burden worldwide (2). Evidence of HCV infection has 
been found in an average of 5% of infants born to HCV 
mothers and ranges between 5 – 36% of children born 
to women co-infected with human immunodeficiency 
virus (HIV) and HCV (3). Furthermore, maternal HCV 
carrier status has been reported as an independent risk 
factor for an adverse perinatal outcome (4).
Despite  the  clinical  sequel  associated  with 
HCV, its epidemiology and risk factors are poorly 
understood, most especially in developing countries 
where intravenous drug abuse (IDU) is uncommon.
In Nigeria, accurate data on HCV distribution 
are elusive, and this situation is compounded by a 
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Background and Aims: The epidemiology and risk factors for hepatitis C virus (HCV) infection in developing countries 
where intravenous drug use (IDU) is uncommon its poorly understood. This study therefore aims to determine the 
prevalence of HCV and its associated risk factors among pregnant women in Calabar municipality. 
Methods: A total of 506 out of 716 antenatal care (ANC) patients seen at the General Hospital, Mary Slessor Avenue, 
Calabar between August and November 2005 and the University of Calabar Teaching Hospital (UCTH) between October 
and November 2005 were evaluated for their HCV status using the One Step HCV Test kit (Binomial diagnostics, UK), with 
reference to the subjects’ demographic and behavioural risk factors. 
Results: HCV prevalence was determined to be 0.4% (2/506) and was only seen in women aged 38 years and over. Histories 
of blood transfusion, surgery, involvement in polygamous marriage, sharing of a toothbrush and female circumcision 
were all non-significant risk factors for the infection.
Conclusions: This study reveals a low HCV prevalence among pregnant women in Calabar municipality with no identifiable 
risk factor. The study calls for a re-evaluation of the transmission modes of HCV especially in developing countries where 
intravenous drug use is rare.
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lack of understating of its natural history. In addition, 
routine diagnosis of infection with the virus is often 
limited to blood donors. In the Cross River State, 
little or no published data exist on the distribution 
of the infection. The practice of blood-transfusion 
screening  of  blood  for  antibodies  to  HCV  (anti-
HCV Ab) emerged barely three years ago, and is 
still limited to only two hospitals located in the state 
capital. Furthermore, with a very limited number of 
women participating as blood donors in most parts 
of the country, including Cross River State, there 
are no baseline data on the distribution of HCV 
among women in the state. In this study we sought 
to  determine  the  prevalence  of  HCV  infection 
among  pregnant  women  against  the  backdrop  of 
their sociodemographic characteristics and reported 
risk  factors,  as  a  means  of  contributing  to  our 
understanding of its natural history. 
Materials and Methods
Study subjects and area
The study subjects were antenatal clinic attendees 
seen  consecutively  between  August and  November 
2005 at the General Hospital, Mary Slessor Avenue, 
Calabar; and at the University of Calabar Teaching 
Hospital Calabar seen between October and November 
2005. The two hospitals serve as the main referral 
hospitals  in  Cross  River  State,  Nigeria. The  Cross 
River State shares an extensive border with Cameroon, 
and has a population of over 3 million. The women 
were aged 15 to 39 years (mean: 29.3 years).
Ethical approval
This study has the ethical approval of the ethical 
committees of both the General Hospital, Calabar 
and  that  of  the  University  of  Calabar  Teaching 
Hospital, Calabar. In addition, individual consent 
was a mandatory requirement for participation.
Administration  of  the  questionnaire  and  sample 
collection 
Each woman was informed of the study and upon 
her agreeing to participate, was counselled on a one-
to-one  basis  before  a  final  consent  to  participate 
was requested. A questionnaire designed to obtain 
information  on  the  women’s  sociodemographic 
characteristics, personal and behavioural risk factors 
was administered to each of those who gave their 
informed consent to participate. The contents of the 
questionnaire were explained in detail, to rule out 
ambiguity or lack of understanding. Explanation was 
in English or in the local dialect. Very literate women 
were allowed to complete the questionnaire on their 
own on the spot, while others had the questionnaire 
completed  on  their  behalf  following  an  oral 
interview. Upon the completion of the questionnaire, 
approximately 5ml of blood were obtained from each 
woman by venipuncture. Samples drawn were allowed 
to  clot  naturally  and  separated  sera  were  divided 
into two aliquots, each stored in Eppendorf tubes. 
Each serum aliquot was kept refrigerated, while the 
duplicates were frozen. The frozen samples served as 
replacements for the original, where insufficiency or 
spillage or contamination of the original refrigerated 
sample occurred.
Screening tests for anti–HCV antibodies 
Detection of anti-HCV Ab was carried out by using 
the  HCV  One  Step  Strip  (Biomill  Diagnostic  kits, 
UK). The second aliquot was preserved frozen, and 
was screened in batches, using the Murex HCV 3.0 
enzyme-linked immunosorbent assay (ELISA) kit (5). 
Results
Study participation 
Only 506 out of the total of 716 antenatal care 
(ANC) women, seen at the two study sites during 
the  study  period,  consented  to  participate  in  the 
study. Refusal reasons include lack of time, 71.2%; 
while lack of husband’s consent was 18.4%; other 
miscellaneous reasons such as fear, nonconformity to 
personal beliefs, or no reason at all, accounted for the 
remaining 10.4%. 
Return of the questionnaire 
Questionnaire return was close to one hundred 
percent (99.6%: 506/508). Two women refused to 
respond to some of the questions asked and were 
excluded from the study.
Prevalence of anti-HCV Ab 
Overall  anti-HCV  Ab  was  only  detected  in  2 
out of the 506 (0.4%) women screened by both the 
HCV 3.0 One Step Strip and the Murex HCV 3.0 
ELISA Test kit. The two positive cases were detected 
in  patients  seen  at  the  General  Hospital,  Calabar 
(0.5%;  2/398).  No  anti-HCV  Ab  was  detected 
among  the  208  women  seen  at  the  University  of 
Calabar Teaching Hospital, Calabar.
Sociodemographic  characteristics,  personal  history 
and HCV distribution among study subjects
A  summary  of  the  sociodemographic 
characteristics and personal history of the women 
studied is presented in Table 1.Hepatitis Monthly, Spring 2010; 10(2): 116-120
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Age, marital status and trimester of pregnancy 
Approximately  6.9%  (35/506)  of  the  women 
were 15 years or less, while over half of them (55%, 
282/506) were aged 16 – 29 years, 37% (188/506) 
were aged 30 – 37, and only 6.1% (31/506) were 
aged 38 years or over. The mean age of the women 
was 29.33 years. Twenty seven (5.3%) of the women 
were single parents, while 93.3 % and 1.4% were 
married  or divorced/widowed,  respectively.  Anti-
HCV Ab was detected in only two women, aged 39 
and 43, respectively.
Trimester  of  pregnancy,  number  of  children  and 
HCV prevalence
 Over  eighty  percent  (81.2%,  411/506)  of  the 
women  screened  were  in  their  second  trimester 
of  pregnancy  and  this  group  accounted  for  the 
two positive cases seen. Similarly, more than three 
quarters of the women had previously had between 
2  –  4  children  (77.1%, 390/506), while  only  8.7 
% (44/506) had five children or more and 12.3% 
(62/506) had either one or no child at all. Anti-HCV 
Ab was detected in one of the women with four 
previous children and in another with nine previous 
pregnancies with seven surviving children.
Risk factors
Only 5.3% (27/506) of the women reported a 
history of blood transfusion, while 2.6% (13/506) 
gave a history of surgery within the past ten years. 
These groups were not associated with anti-HCV 
Ab.  An  HCV  prevalence  of  0.4%  (2/479)  and 
0.41% (2/493) was detected in those with no history 
of blood transfusion, and those without any history 
of  surgery  within  the  past  ten  years,  respectively. 
Similarly,  involvement  in  polygamous  marriage, 
sharing of a toothbrush and a history of tattoos or 
female  circumcision  were  all  not  considered  risk 
factors for the distribution of HCV in this study. 
Over  five  percent  of  the  women  were  single 
parents 5.37 (27/506) while 93.3% (472/506) were 
married and 1.4% (7/506) was either divorced or 
widowed. Anti- HCV Ab was only detected among 
the married women (0.4%; 2/472) (Table 2). 
Table 1. HCV prevalence according to age, marital 
status and number of children.
Parameter No. Involved 
(n=506)
No. HCV Positive 
(n=2, %)
Age (years)
≤15 35(6.9) 0
16-23 90(17.8) 0
23-29 192(37.9) 0
20-37 188(37.2) 0
≥38 31(6.1) 2(0.06)
Marital Status 
Single 27(5.3) 0
Married 472(93.3) 2 (0.004)
Divorced/widowed 7(1.4) 0
Trimester of Pregnancy
1st 43(8.5) 0
2nd  411(81.2) 2(0.005)
3rd 42(8.3) 0
Number of Children
0-1  62(12.3) 0
2-4 390(77.1) 1(0.3)
≥5 44(8.7) 1(2.3)
Table 2. Prevalence of HCV according to risk factor.
Parameter No. Involved (n=506) No. HCV Positive (n=2)
History of Blood Transfusion within the Past 10 Years 
Yes 27(5.3) 0(0)
 No 479(94.7) 2(0.004)
History of Surgery within the Past 10 Years 
Yes 13(2.6) 0(0)
No 493(94.7) 2(0.004)
Involvement in Polygamous Marriage
Yes 50(9.9) 0(0)
No 456(90.1) 2(0.004)
Sharing of Tooth Brush 
Yes 24(4.7) 0(0)
No 482(92.5) 2(0.004)
History of Tattoo 
Yes 6(0.2) 0(0)
No 500 (99.8) 2(0.004)
Sharing of Injection Needle 
Yes 0(0)
No 506 (100) 2(0.004)
History of Circumcision
Yes 77(15.2) 0
No 429 (84.8) 2(0.005)Hepatitis Monthly, Spring 2010; 10(2): 116-120
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Intravenous drug use/injection needle sharing
None of the women admitted ever being involved 
in intravenous drug use or in the sharing of injection 
needles.
Discussion
Studies of infection with HCV in the West Africa 
region are becoming important and necessary because 
of the emerging evidence of high HCV prevalence (6, 7) 
against a backdrop of unidentified risk factors.
The  finding  of  an  HCV  prevalence  of  0.4% 
(2/506) in this study, though comparatively low, is 
however similar to the findings of Mboto et al. (8), 
in  a  similar  study  conducted  in  Gambia.  It  also 
similar to the Onakewhor and Okonofua (9) report 
of an HCV prevalence of 1.86% in 269 booked 
consecutive antenatal women volunteers attending 
the University of Benin Teaching Hospital, Benin 
City. Contrary to these findings, however, Halim 
and Ajayi (10) in a survey of two hundred and sixty 
healthy  volunteer  male  blood  donors  aged  20-
54 years, found an HCV prevalence of 12.3% in 
Benin , the capital city of Edo State, suggesting a 
major disparity due to a difference in sex. Although 
the study subjects enlisted by Halim and Ajayi (10) 
were male blood donors, as compared to pregnant 
women in this study, both groups belong to the low 
risk class, most especially in terms of transmission of 
sexually transmitted diseases (STD).
However, the finding of significantly higher anti-
HCV Ab prevalence in males by Halim and Ajayi (10) 
is similar to the Nwankiti et al. (11), report of an HCV 
prevalence of 14.36% in apparently healthy individuals 
with a family history of diabetes in Vom, Plateau State. 
This sex difference cannot be sufficiently explained 
against a backdrop of unidentified risk factors, most 
especially as intravenous drug abuse is rare in this part 
of the world. However, some studies have shown a 
significant number of persons clear HCV from their 
blood after infection, with a higher clearance rate in 
females than males (12). We do not know if this higher 
clearance rate in females can sufficiently explain the 
low HCV prevalence found in this study and the 
comparatively higher prevalence reported in men by 
two independent studies (10, 11).
Laurent et al. (13), in a similar study conducted 
among  commercial  sex  workers  and  pregnant 
women  in  Kinshasa,  Democratic  Republic  of 
Congo,  observed  that  parenteral  transmission 
predominantly by means of blood transfusion and 
STI treatment-related injections, may play a major 
role in HCV distribution, while sex was considered 
a limited factor. In this study, anti-HCV Ab was 
not detected in any of the women with a history of 
blood transfusion. Furthermore, its nondetection 
in women with a history of surgery within the part 
ten years, with a history of sharing of a toothbrush, 
a history of tattoos, and of circumcision, all reveals 
the insignificant role of these modes of transmission 
in the distribution of HCV in this region. However, 
the 0.4% (2/479) of the women who were infected 
with  the  virus  in  this  study  reported  no  history 
of blood transfusion, nor surgery within the past 
ten years, nor sharing of a toothbrush nor history 
of tattoos or female circumcision. These persons 
infected  with  the  virus  with  no  identifiable  risk 
factors sum up the problems associated with HCV 
studies in the region. Several studies have observed 
significantly  high  HCV  prevalence  in  subjects 
with no apparent risk factors (3, 6-8). This finding 
therefore suggests the need for a longitudinal study 
that would evaluate some salient cultural practices 
that  may  facilitate  HCV  transmission  in  the 
region.
Generally,  sexual  transmission  of  HCV  is 
considered to be rare, and some studies have shown 
that the risk of HCV transmission in heterosexual or 
monogamous relationships is very rare or even null 
(14-16). However, HCV transmission is enhanced in 
persons co-infected with HIV (3, 17). In this study, 
the spousal HCV or HIV status of these women 
was not evaluated. There is therefore a need for 
studies aimed at evaluating couples for their HCV 
status against a background of their prevailing risk 
factors.
Age has been argued as a major factor in HCV 
studies, with infection more predominant in older 
persons (18, 19). This may be due to the prolonged 
period of incubation of the virus, or to the fact 
that more people were infected in the developed 
world before 1989 (20), when diagnostic facilities 
emerged. In a study conducted in 2000 in Egypt, 
Abdel-Aziz (21) found anti-HCV Ab prevalence to 
increase sharply with increasing age; with persons 
currently or previously married more likely to be 
seropositive than those who never married. In this 
study, anti-HCV Ab was found only in two women, 
aged  38  and  41  years  (mean  38.5years),  both 
married and in their second trimester of pregnancy. 
The  significance  of  these  ages  in  terms  of  time 
of infection and mode of transmission cannot be 
inferred from the available data and calls for further 
study.
Some  studies  have  revealed  that  the  detection 
of  anti-HCV  Ab  may  yield  a  high  frequency  of 
false-positive results in people at low risk (22). The 
contributory  role  of  this  to  the  HCV  prevalence 
found in this study has no simple explanation. Hepatitis Monthly, Spring 2010; 10(2): 116-120
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Conclusions
This  study  has  provided  some  baseline  data  on 
the distribution of HCV among pregnant women in 
this part of the country, and reveals a significantly low 
prevalence, as compared to rates reported in males in 
some other parts of the country. The infected women 
were 38 years or over, and have no identifiable risk 
factors, demonstrating the need for a re-evaluation of 
the transmission routes of HCV, especially in developing 
countries, where intravenous drug use is rare.
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